Medical devices, healthcare technology and the business of care
510(k) clearance · K261585

Diagnostic Ultrasound System (Nuewa A20W); Diagnostic Ultrasound System (Nuewa A20); Diagnostic Ultrasound System (Nuewa A20 Exp); Diagnostic Ultrasound System (Nuewa A20 Elite); Diagnostic Ultrasound System (Nuewa A20Q); Diagnostic Ultrasound System (Nuewa A MV); Diagnostic Ultrasound System (Nuewa A Elite); Diagnostic Ultrasound System (Nuewa A MS); Diagnostic Ultrasound System (Nuewa A20 Premium); Diagnostic Ultrasound System (Nuewa A20 Plus); Diagnostic Ultrasound System (Nuewa A18

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK261585

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-16 for K261585, a traditional 510(k) submitted 05/13/2026 by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. of Shenzhen, CN. The listed device name covers multiple Diagnostic Ultrasound System models under the Nuewa A20 and Nuewa A families, including A20W, A20, A20 Exp, A20 Elite, A20Q, A MV, A Elite, A MS, A20 Premium, A20 Plus and A18. The classification name is System, Imaging, Pulsed Doppler, Ultrasonic, under regulation 892.1550, product code IYN, with subsequent codes ITX and IYO.

The review panel and medical specialty are Radiology; the submission was not reviewed by a third party, is not a combination product, and no Predetermined Change Control Plan was authorized. SESE means the submission was cleared as substantially equivalent, not granted PMA approval. The source does not describe the specific component, software or design change at issue, nor any indications for use, so those details remain unknown here and would require the underlying 510(k) documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 16, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261585
Regulatory pathway
510(k) premarket notification
Product code
IYN
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.

Product code
IYN
FDA device class
2

FDA decision timeline

  1. K261585 received

    Application receipt date recorded by FDA.

  2. K261585 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYN

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 8, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceOct 8, 2026FDA
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC510(k) clearanceOct 2, 2026FDA
Philips Ultrasound, LLC510(k) clearanceSep 25, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records